- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Spruce Biosciences Inc (SPRB)
Assess today's live Spruce Biosciences Inc (SPRB) share price, performance and insights using our live NASDAQ: SPRB stock exchange data.
Analyse the historical data and Spruce Biosciences Inc share price performance charts on this page. Our technical summary section provides analysis on Spruce share price buy/sell indicators using real-time data (or discuss the Spruce (SPRB) stock price today with other investors in the Spruce NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ SPRB share price (ISIN: US85209E2081) to enhance your trading decisions with our free investment tools and resources.
What Is the Spruce Biosciences Inc Share Price Today?
The Spruce share price today is 83.7400.
What Is the Stock Symbol for Spruce Biosciences Inc
The stock symbol (or 'ticker') for Spruce Biosciences Inc is "SPRB."
What Stock Exchange Does Spruce Biosciences Inc Trade On?
Spruce Biosciences Inc is listed and trades on the NASDAQ stock exchange.
Is Spruce Biosciences Inc a Good Stock to Buy?
Determining whether Spruce Biosciences Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Spruce Biosciences Inc share price performance charts on this page. Our technical summary section provides analysis on Spruce share price buy/sell indicators using real-time data (or discuss the Spruce (SPRB) stock price today with other investors in the Spruce NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ SPRB share price (ISIN: US85209E2081) to enhance your trading decisions with our free investment tools and resources.
What Is the Spruce Biosciences Inc Share Price Today?
The Spruce share price today is 83.7400.
What Is the Stock Symbol for Spruce Biosciences Inc
The stock symbol (or 'ticker') for Spruce Biosciences Inc is "SPRB."
What Stock Exchange Does Spruce Biosciences Inc Trade On?
Spruce Biosciences Inc is listed and trades on the NASDAQ stock exchange.
Is Spruce Biosciences Inc a Good Stock to Buy?
Determining whether Spruce Biosciences Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
NASDAQ
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
82.9500
87.1100
52 wk Range
4.2750
240.0000
SPRB is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
82.950087.1100
52 wk Range
4.2750240.0000
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
SPRB Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Strong Buy
Price Target
230.5000
Upside
+175.26%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock generally trades with high price volatility
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Buy
Moving Averages
Sell
Spruce Company Profile
Spruce Biosciences, Inc. is a biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders. The company develops TA-ERT, a fusion protein comprised of recombinant human alpha-N-acetylglucosaminidase, which is an enzyme replacement therapy for patients with Sanfilippo Syndrome Type B. It also develops Tildacerfont for treating a highly debilitating mental disorder characterized by depressed mood with cognitive-affective and somatic changes, including anhedonia, weight alterations, and altered sleeping patterns. In addition, the company develops SPR202 for the treatment of Congenital Adrenal Hyperplasia (CAH), a chronic and potentially life-threatening rare disease with no cure, and SPR204, a monoclonal antibody antagonist for Post-Bariatric Hypoglycemia. The company has a license agreement with Eli Lilly and Company to research, develop, and commercialize various pharmaceutical compounds. It also has a collaboration and license agreement with Kaken Pharmaceutical Co. Ltd. to develop, manufacture, and commercialize Tildacerfont for the treatment of CAH in Japan. Spruce Biosciences, Inc. was incorporated in 2014 and is headquartered in South San Francisco, California.
Spruce Biosciences Inc SWOT Analysis
Tildacerfont Trials | Spruce Biosciences' future hinges on pivotal CAHmelia-204 and CAHptain-205 trials for tildacerfont, with results expected in Q4 2024 |
Market Dynamics | Explore the competitive landscape of CAH treatment, with Spruce facing challenges from Neurocrine Biosciences' crinecerfont in a market of 20,000-30,000 US patients |
Financial Health | With $70M cash runway through 2025, Spruce Biosciences navigates critical development phases while exploring strategic alternatives to maximize shareholder value |
Analyst Outlook | Price targets range from $1.50 to $3.00, reflecting varied perspectives on Spruce's potential in CAH treatment and expansion into Major Depressive Disorde |
Compare SPRB to Peers and Sector
Metrics to compare | SPRB | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSPRBPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.9x | −4.9x | −0.6x | |
PEG Ratio | 0.13 | 0.13 | 0.00 | |
Price/Book | 16.6x | 7.8x | 2.6x | |
Price / LTM Sales | 128.6x | 43.0x | 3.2x | |
Upside (Analyst Target) | 165.6% | 52.6% | 41.8% | |
Fair Value Upside | Unlock | −8.9% | 5.1% | Unlock |
Analyst Ratings
4 Buy
0 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 230.5000
(+175.26% Upside)
Earnings
Latest Release
Nov 10, 2025
EPS / Forecast
-14.58 / -0.215
Revenue / Forecast
-- / 250.00K
People Also Watch
FAQ
What Is the Spruce (SPRB) Share Price Today?
The live Spruce share price today is 83.7400
What Stock Exchange Does Spruce (SPRB) Trade On?
Spruce is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Spruce?
The stock symbol (also called a 'ticker') for Spruce is "SPRB."
What Is the Current Spruce Market Cap?
As of today, Spruce market capitalisation is 89.63M.
What Is Spruce's (SPRB) Earnings Per Share (TTM)?
The Spruce EPS is currently -82.48 (Trailing Twelve Months).
When Is the Next Spruce Earnings Date?
Spruce's next earnings report will be released on 17 Nov 2025.
Is SPRB a Buy or Sell From a Technical Analyst Perspective?
Based on today's Spruce moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Spruce Stock Split?
Spruce has split 1 times. (See the SPRB stock split history page for full effective split date and price information.)
How Many Employees Does Spruce Have?
Spruce has 9 employees.
What is the current trading status of Spruce (SPRB)?
As of 24 Dec 2025, Spruce (SPRB) is trading at a price of 83.7400, with a previous close of 83.7400. The stock has fluctuated within a day range of 82.9500 to 87.1100, while its 52-week range spans from 4.2750 to 240.0000.
What Is Spruce (SPRB) Price Target According to Analysts?
The average 12-month price target for Spruce is USD230.5, with a high estimate of USD283 and a low estimate of USD160. 4 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +175.26% Upside potential.
What Is the SPRB After Hours Price?
SPRB's last after hours stock price is 81.3400, the stock has decreased by -2.4000, or -2.8700%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.